CAVHANZA
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99699122
- Mark type
- Stylized text
- Filed
- 12 Mar 2026
- Published for opposition
- 21 Jul 2026
- Attorney of record
- James A Wahl
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia
Owner
- FLEX PHARMA, LLC, MINNEAPOLIS, MN, US
- FLEX PHARMA, LLC, MINNEAPOLIS, MN, US
Prosecution history
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jun 2026 — ASSIGNED TO EXAMINER
- 12 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Mar 2026 — NEW APPLICATION ENTERED